相似文献
1
Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.
Circ Res. 2021 Aug 6;129(4):e54-e71. doi: 10.1161/CIRCRESAHA.121.319142. Epub 2021 Jul 9.
2
Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome.
Arterioscler Thromb Vasc Biol. 2021 Sep;41(9):2509-2511. doi: 10.1161/ATVBAHA.121.316210. Epub 2021 Jul 15.
3
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response.
J Leukoc Biol. 1997 Apr;61(4):408-14. doi: 10.1002/jlb.61.4.408.
4
Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes.
J Immunol. 2011 Jun 1;186(11):6263-70. doi: 10.4049/jimmunol.1003824. Epub 2011 Apr 25.
5
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort.
Br J Anaesth. 2021 Aug;127(2):e75-e78. doi: 10.1016/j.bja.2021.05.013. Epub 2021 May 27.
6
Mononuclear-macrophages but not neutrophils act as major infiltrating anti-leptospiral phagocytes during leptospirosis.
PLoS One. 2017 Jul 11;12(7):e0181014. doi: 10.1371/journal.pone.0181014. eCollection 2017.
7
The mononuclear phagocyte system.
Curr Opin Immunol. 2006 Feb;18(1):49-53. doi: 10.1016/j.coi.2005.11.008. Epub 2005 Dec 9.
8
Purified human and recombinant murine interleukin-1 alpha induced accumulation of inflammatory peritoneal neutrophils and mononuclear phagocytes: possible contributions to antibacterial resistance.
Microb Pathog. 1987 Nov;3(5):377-86. doi: 10.1016/0882-4010(87)90007-6.
9
Phagocyte partnership during the onset and resolution of inflammation.
Nat Rev Immunol. 2010 Jun;10(6):427-39. doi: 10.1038/nri2779.
10
Oxidative stress in phagocytes--"the enemy within".
Microsc Res Tech. 2002 Jun 15;57(6):441-55. doi: 10.1002/jemt.10098.
引用本文的文献
1
The potential of exogenous specialized pro-resolving mediators in protecting against sepsis-associated lung injury: a review.
Front Pharmacol. 2025 Jul 29;16:1622754. doi: 10.3389/fphar.2025.1622754. eCollection 2025.
2
Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era.
Cancer Med. 2025 Jul;14(14):e71082. doi: 10.1002/cam4.71082.
3
Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates.
PLoS One. 2025 Jun 5;20(6):e0324987. doi: 10.1371/journal.pone.0324987. eCollection 2025.
4
Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes.
Int J Mol Sci. 2024 Jun 24;25(13):6917. doi: 10.3390/ijms25136917.
5
Biology and Total Synthesis of n-3 Docosapentaenoic Acid-Derived Specialized Pro-Resolving Mediators.
Molecules. 2024 Jun 14;29(12):2833. doi: 10.3390/molecules29122833.
6
Identification of novel F-isoprostane metabolites by specific UDP-glucuronosyltransferases.
Redox Biol. 2024 Apr;70:103020. doi: 10.1016/j.redox.2023.103020. Epub 2024 Jan 4.
7
Efferocyte-Derived MCTRs Metabolically Prime Macrophages for Continual Efferocytosis via Rac1-Mediated Activation of Glycolysis.
Adv Sci (Weinh). 2024 Feb;11(7):e2304690. doi: 10.1002/advs.202304690. Epub 2023 Dec 8.
8
Arachidonate 15-lipoxygenase-mediated production of Resolvin D5 abrogates pancreatic stellate cell-induced cancer cell invasion.
Front Immunol. 2023 Nov 16;14:1248547. doi: 10.3389/fimmu.2023.1248547. eCollection 2023.
9
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators.
Exp Biol Med (Maywood). 2023 Oct;248(19):1635-1644. doi: 10.1177/15353702231199082. Epub 2023 Oct 14.
10
Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2302070120. doi: 10.1073/pnas.2302070120. Epub 2023 Aug 21.
本文引用的文献
1
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.
Sci Transl Med. 2021 Jan 27;13(578). doi: 10.1126/scitranslmed.abe8146. Epub 2021 Jan 11.
2
Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients.
Front Microbiol. 2020 Dec 23;11:600989. doi: 10.3389/fmicb.2020.600989. eCollection 2020.
3
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6.
4
Immunopathogenesis and treatment of cytokine storm in COVID-19.
Theranostics. 2021 Jan 1;11(1):316-329. doi: 10.7150/thno.49713. eCollection 2021.
5
Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.
Cell Host Microbe. 2021 Feb 10;29(2):222-235.e4. doi: 10.1016/j.chom.2020.12.016. Epub 2020 Dec 26.
6
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
J Immunol. 2021 Jan 15;206(2):329-334. doi: 10.4049/jimmunol.2001025. Epub 2020 Dec 4.
7
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates.
Nat Commun. 2020 Nov 27;11(1):6078. doi: 10.1038/s41467-020-19967-4.
8
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi: 10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24.
9
A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
Trends Immunol. 2021 Jan;42(1):3-5. doi: 10.1016/j.it.2020.10.012. Epub 2020 Nov 2.
10
Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19.
Pharmacol Ther. 2021 May;221:107745. doi: 10.1016/j.pharmthera.2020.107745. Epub 2020 Nov 11.
Zotero 插件